Cargando…
Gemcitabine-induced heparanase promotes aggressiveness of pancreatic cancer cells via activating EGFR signaling
Pancreatic cancer (PC), characterized by aggressive local invasion and metastasis, is one of the most malignant cancers. Gemcitabine is currently used as the standard drug for the treatment of advanced and metastatic PC, but with limited efficacy. In this study, we demonstrated that gemcitabine incr...
Autores principales: | Song, Jin-Wen, Tan, Ying-Xia, Li, Su-Bo, Zhang, Shi-Kun, Wan, Lu-Ming, Ji, Shou-Ping, Zhou, Hong, Zhou, Zhi-Hang, Gong, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601663/ https://www.ncbi.nlm.nih.gov/pubmed/28938567 http://dx.doi.org/10.18632/oncotarget.16911 |
Ejemplares similares
-
Heparanase Promotes Tumor Growth and Liver Metastasis of Colorectal Cancer Cells by Activating the p38/MMP1 Axis
por: Liu, Xue, et al.
Publicado: (2019) -
Regulation of Heparanase in Diabetes-Associated Pancreatic Carcinoma
por: Goldberg, Rachel, et al.
Publicado: (2019) -
Smad4 suppresses the tumorigenesis and aggressiveness of neuroblastoma through repressing the expression of heparanase
por: Qu, Hongxia, et al.
Publicado: (2016) -
Heparanase expression upregulates platelet adhesion activity and thrombogenicity
por: Cui, Hao, et al.
Publicado: (2016) -
Accelerated Resolution of AA Amyloid in Heparanase Knockout Mice Is Associated with Matrix Metalloproteases
por: Wang, Bo, et al.
Publicado: (2012)